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Cohen syndrome is a rare autosomal recessive disorder with a variable clinical picture mainly characterized by
developmental delay, mental retardation, microcephaly, typical facial dysmorphism, progressive pigmentary reti-
nopathy, severe myopia, and intermittent neutropenia. A Cohen syndrome locus was mapped to chromosome 8q22
in Finnish patients, and, recently, mutations in the gene COH1 were reported in patients with Cohen syndrome
from Finland and other parts of northern and western Europe. Here, we describe clinical and molecular ﬁndings
in 20 patients with Cohen syndrome from 12 families, originating from Brazil, Germany, Lebanon, Oman, Poland,
and Turkey. All patients were homozygous or compound heterozygous for mutations in COH1. We identiﬁed a
total of 17 novel mutations, mostly resulting in premature termination codons. The clinical presentation was highly
variable. Developmental delay of varying degree, early-onset myopia, joint laxity, and facial dysmorphism were the
only features present in all patients; however, retinopathy at school age, microcephaly, and neutropenia are not
requisite symptoms of Cohen syndrome. The identiﬁcation of novel mutations in COH1 in an ethnically diverse
group of patients demonstrates extensive allelic heterogeneity and explains the intriguing clinical variability in
Cohen syndrome.
Cohen syndrome (MIM 216550), an infrequent reces-
sively inherited condition, was described ﬁrst by Cohen
et al. (1973). Initially, it was characterized by distinctive
craniofacial appearance, midchildhood onset of obesity,
mental retardation, hypotonia, joint laxity, and narrow
hands and feet. A clinically homogeneous phenotype of
Cohen syndrome was reported in Finnish patients who
showed additional ophthalmological ﬁndings, namely,
progressive myopia and retinal dystrophy, microcephaly,
and neutropenia (Norio et al. 1984; Kivitie-Kallio et al.
1999; Kivitie-Kallio and Norio 2001). In these patients,
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the similar and characteristic craniofacial appearance,
which becomes more speciﬁc with age, includes down-
ward slanting and wave-shaped palpebral ﬁssures, short
philtrum, heavy eyebrows, thick hair, and a prominent
root of the nose. In the same cohort, the underlying gene
was localized to the vicinity of D8S1762 on chromosome
8q22 (Tahvanainen et al. 1994; Kolehmainen et al.
1997). Greater, and often confusing, clinical variability
in Cohen syndrome was described in cases from outside
Finland. Different clinical criteria were determined in
studies of non-Finnish patients (Horn et al. 2000; Chan-
dler et al. 2003).
An overlapping phenotype between Cohen syndrome
and Mirhosseini-Holmes-Walton syndrome (MIM
268050) was observed in three closely related patients
from a multiply consanguineous kindred of Lebanese
descent (Horn et al. 2000). These patients presentedwith
postnatal microcephaly, progressive growth delay, and
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Figure 1 Facial photographs of patients, showing mild but characteristic facial dysmorphism of Cohen syndrome. Shown are patients 10
(A), 7 (B), 2/2 (C), 2/1 (D), 4 (E), and 11/3 (F). Their ages are 2 years, 2 years, 1 year, 4 years, 4.5 years, and 8 years, respectively.
severe mental retardation. Homozygosity mapping in
this family assigned the underlying gene to a region on
chromosome 8q21.3-22.1 that extended over the gene
region associated with Cohen syndrome in Finnish pa-
tients (Horn et al. 2000). Mirhosseini-Holmes-Walton
syndrome in two families with microcephaly, retinal pig-
mentary degeneration, and severe mental retardation
was described elsewhere (Mirhosseini et al. 1972; Men-
dez et al. 1985). Clinical presentation in these cases has
features in common with the phenotype seen in patients
with Cohen syndrome, which suggests that both con-
ditions represent the same clinical entity (Norio and
Raitta 1986; Steinlein et al. 1991; Horn et al. 2000).
Recently, mutations of the COH1 gene were reported
in a northern and western European cohort of patients
with Cohen syndrome, mainly originating from Finland
(Kolehmainen et al. 2003). COH1 comprises various
splice forms and up to 62 exons and encodes a protein
of 4,022 aa whose domain structure and sequence sim-
ilarities suggest a role in protein sorting and vesicle-
mediated protein transport.
The present study describes clinical and molecular
ﬁndings in 20 patients with Cohen syndrome from 12
non-Finnish families. The investigated families com-
prised a consanguineous Omani family with three af-
fected sibs (family 9; see table 1); two consanguineous
Turkish families, each with one affected child and one
unaffected sib (families 3 and 12); two nonconsanguin-
eous Polish families, each with two affected sibs (families
2 and 8); four nonconsanguineous German families,
each with one affected child (families 4, 6, 7, and 10);
and one nonconsanguineous Brazilian family with two
affected children (family 1). Three patients—two broth-
ers and one cousin—showing symptoms of Cohen and
Mirhosseini-Holmes-Walton syndromes originated from
a multiply consanguineous Lebanese family that also in-
cluded two and three unaffected siblings of the brothers
and cousin, respectively (family 11). Detailed clinical
data and results of homozygosity mapping in this family
were reported elsewhere (Horn et al. 2000). Another
nonconsanguineous German family with two affected
sibs (family 5) was suggested also as having an overlap-
ping phenotype and was described elsewhere by Steinlein
et al. (1991).
Informed consent was obtained from all parents. Pa-
tients were assessed clinically by at least one of the au-
thors. DNA was extracted from peripheral blood with
the use of standard methods. From the COH1 region
on chromosome 8q22, 36 microsatellite markers were
analyzed in consanguineous families. Primer pairs for
ampliﬁcation of each of the 62 COH1 exons were
generated on the basis of the sequence of a chromo-
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Figure 2 Facial features of two older patients with Cohen syndrome. A, Patient 3, age 13 years. B, Patient 11/1, age 17 years.
some 8 genomic contig (GenBank accession number
NT_008046). Exons were sequenced directly by BigDye
Terminator sequencing (Applied Biosystems). RNA was
extracted from lymphoblastoid cell lines. Primer pairs
for RNA ampliﬁcation were designed from the sequence
of the partial transcript KIAA0532 (GenBank accession
number AB011104) and the cDNA sequence of COH1
(GenBank accession number NM_017890). Primer se-
quences are available on request.
The characteristic facial appearance, developmental
delay, myopia, narrow hands with slender and tapering
ﬁngers, narrow feet, and generalized joint hyperexten-
sibility were present in all patients with Cohen syndrome
investigated for this study. However, microcephaly, short
stature, truncal obesity, neutropenia, and retinopathy
were not present in some of the patients (table 1). Mea-
surement of head circumference at birth revealed values
within normal limits in all cases. Patients’ occipitofrontal
head circumference varied from 5.9 to 1.5 SD post-
natally, and values were 3rd percentile for age in all
cases but one. Heights were highly variable and ranged
from 5.7 to 0.3 SD. Short stature (height 3rd per-
centile) was present in 11 of 20 cases. Truncal obesity
was found in 13 of the 20 patients but was mild,
especially in younger patients. The youngest patient
with this symptom (patient 7) was 2 years of age.
All patients had a global developmental delay of var-
iable degree and nonprogressive mental retardation. The
median age at unsupported sitting was 17 mo and at
ﬁrst walking was 3 years. Six patients (4, 5/2, 7, 11/1,
11/2, and 12) did not achieve verbal communication,
and the others, with a median age of 3 years at ﬁrst
spoken words, used single words only or were able to
speak in short sentences.
In the younger patients, the face was round with a
full lower lip, the philtrum was not obviously short, the
eyes were often slightly downward slanting with wave-
shaped eyelids, and the nasal bridge was not prominent
(ﬁg. 1A–1F). However, the facial appearance was rec-
ognizable in young age and led to the diagnosis of Cohen
syndrome, even in the absence of ophthalmologic ﬁnd-
ings, in two 24-mo-old patients without a striking family
history (patients 7 and 10; see ﬁg. 1A and 1B). With
increasing age, the facial gestalt became more typical,
with thick hair, often a low frontal hairline, heavy eye-
brows, short philtrum, a long columella further con-
tributing to the impression of a short philtrum, and cen-
tral incisors that may appear prominent (ﬁg. 2A and
2B).
All patients studied here had visual abnormalities. An
early-onset myopia with a severity from 2.5 to 13
diopters was a nearly consistent ﬁnding. One patient (10)
had only very mild myopia of 0.3 diopters at the ages
of 2 years and 4 years. However, pigmentary retinopa-
thy, which is an age-dependent symptom, was absent in
a total of seven patients (1/1, 1/2, 2/1, 2/2, 4, 7, and
10), ages 3–15 years. Severe ophthalmological ﬁndings,
necessitating enucleation in patients 5/1 and 5/2, in-
cluded total retinal detachment and optic atrophy in
both patients and shrunken vitreous body and the pres-
ence of eosinophilic material in the retroretinal space in
one of them.
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Table 2
Mutations in COH1 Identiﬁed in 12 Cases of Cohen Syndrome
cDNA Exon Protein Genotype Family Origin
c.1504CrT 11 p.Arg502X Heterozygous 1 Brazilian
c.2727_2730dupGCTC 19 p.Asn911fsX3 Homozygous 2 Polish
c.2911CrT 20 p.Arg971X Homozygous 3 Turkish
c.3618TrA 24 p.Cys1206X Heterozygous 4 German
c.4396insA 29 p.Thr1466fsX5 Heterozygous 5 German
c.5069TrA 32 p.Leu1690X Heterozygous 6 German
c.7022ArG 39 p.Tyr2341Cys Heterozygous 7 German
c.7603CrT 42 p.Arg2535X Heterozygous 4 German
c.7610GrA 42 p.Trp2537X Heterozygous 6 German
c.7934GrA 43 p.Gly2645Asp Homozygous 9 Omani
c.7935delC 43 p.Gln2646fsX96 Heterozygous 8 Polish
c.8609delA 47 p.Glu2870fsX16 Heterozygous 10 German
c.9406-1GrT 52 p.Tyr3136fsX16 Homozygous 11 Lebanese
c.9731delA 53 p.Tyr3244fsX7 Heterozygous 10 German
c.10888CrT 56 p.Gln3630X Homozygous 12 Turkish
c.11216GrA 58 p.Trp3739X Heterozygous 5 German
c.11314CrT 59 p.Gln3772X Heterozygous 7 German
Repeated hematological examinations showed neu-
tropenia, deﬁned as a neutrophil count !1.5# 109/l, in
10 of 18 patients. Severe infections were not reported
in the patients with neutropenia studied here.
With the use of microsatellite markers, homozygosity
in the COH1 region was found in all patients from con-
sanguineous families, with a critical interval between
D8S343 and D8S1714. In the full-length transcript of
COH1, 17 different novel mutations were identiﬁed (ta-
ble 2). They cosegregated in the respective families in all
cases and were not seen in 150 chromosomes from con-
trol subjects. As expected, patients from the consan-
guineous families 3, 9, 11, and 12 carried homozygous
mutations. Moreover, the two Polish patients from fam-
ily 2 without known consanguinity were homozygous
for aCOH1mutation. Further analysis ofmicrosatellites
around COH1 in this family showed a small homozy-
gous interval between D8S257 and D8S546, which is
1.5 cM in length, pointing to a more distant relationship
in this family. Seven further cases had heterozygous
mutations.
Mutation c.9406-1GrT, identiﬁed in family 11, af-
fected the splice-acceptor site of intron 51. To investigate
whether the mutation resulted in exon skipping or re-
tention of intron 51, RNA samples of two affected cous-
ins and an unaffected brother from the family were an-
alyzed. However, direct sequencing of cDNA revealed
that a cryptic splice site is activated in exon 52 and is
used as the acceptor site instead of the mutant one in
intron 51 (ﬁg. 3). The defective splicing leads to deletion
of 16 exonic bases and, thus, a frameshift in the COH1
mRNA. The genomic sequence 5′ of the new splice site,
ATTTTCGTGTTCCAG, is consistent with the consen-
sus sequence at 11 of 14 relevant positions, including
the highly conserved bases AG at the end of the motif.
In contrast, the normal splice-acceptor site of intron 51
fully complies with the consensus.
Mutations occurred throughout the gene, and each
mutation was seen only in one case. Interestingly, only
2 of 17 mutations were missensemutations, Tyr2341Cys
and Gly2645Asp, both of which introduce dissimilar
residues. All other mutations were either nonsense
(9 mutations) or frameshift mutations (6 mutations)
leading to premature termination codons. Among 27
Finnish patients investigated by Kolehmainen et al.
(2003), 26 had at least one allele with the mutation
c.3348_3349delCT. In contrast to those results, themost
frequent mutation in Finnish patients was not found in
the series of patients reported here. Moreover, eight fur-
ther mutations, identiﬁed in patients whose ancestors
were from the United Kingdom, Belgium, and Denmark
(Kolehmainen et al. 2003), also were not found in this
study group. These ﬁndings demonstrate an extensive
allelic heterogeneity of Cohen syndrome and the lack of
a mutational hotspot in COH1, with the exception of
the major mutation found in Finnish patients, the fre-
quency of which probably results from a founder effect.
In two patients (families 1 and 8), only one mutation
each was identiﬁed. These patients also were assumed
to be compound heterozygous. The lack of a second
mutation may be because of mutations in alternative
exons, which are present in the shorter splice variants
of COH1 (Kolehmainen et al. 2003). Alternatively, some
further mutations could reside within intronic sequences,
which were analyzed only at the conserved splice sites,
or could represent larger deletions.
The function of the protein encoded by COH1 is
mostly unknown. The search for conserved domains in
the predicted protein with the use of RPS-BLAST and
the Pfam (Bateman et al. 2004), ProDom (Corpet et al.
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Figure 3 Sequence analysis of COH1 in probands from the Lebanese family with Cohen syndrome (family 11). A, Splice mutation c.9406–
1GrT, identiﬁed in DNA samples from two affected cousins, altering the splice acceptor site of intron 51. The position of the mutation is
marked by an arrow. B, Analysis of RNA samples showing the activation of a cryptic splice site in exon 52, which leads to a frameshift because
of a 16-bp deletion.
2000), and Prosite (Falquet et al. 2002) databases-
revealed two signiﬁcantly conserved regions at the N-
terminus and close to the C-terminus, both regions with
similarities to protein domains associated with vacuolar
protein sorting, as described elsewhere (Kolehmainen et
al. 2003). Detailed sequence alignments with PSI-BLAST
(Altschul et al. 1997) identiﬁed similarities to Vps13p,
a yeast protein associated with vacuolar protein sorting,
also known as Soi1p (Redding et al. 1996; Brickner and
Fuller 1997). The phylogeny, as depicted with the neigh-
bor-joining method (Saitou and Nei 1987), indicated the
rather close relationship of Vps13p-like proteins from
distinct species (ﬁg. 4), pointing to a potentially more
general role of this protein.
The families analyzed here were from different ethnic
groups with a wide geographic distribution, including
families of German, Turkish, Polish, Lebanese, Omani,
and Brazilian descent. Greater clinical variability was
observed in these patients with Cohen syndrome in com-
parison to Finnish patients with Cohen syndrome.
Clinical homogeneity in the Finnish patients may be
the result of the high frequency of a single mutation,
c.3348_3349delCT, and may represent the phenotype of
this speciﬁc allele. In Finnish patients, the degree of mi-
crocephaly at infancy is generally 3–5 SD below the
mean. In the cohort reported here, head circumference
had a broader variability, from the lower end of the
normal range to very severe expression. Therefore, ab-
sence of microcephaly does not rule out the diagnosis
of Cohen syndrome. This conﬁrms the clinical results
reported by Chandler et al. (2003), who observed ab-
sence of microcephaly in 10% of their patients, mainly
from the United Kingdom.
Further variability was observed in growth develop-
ment. Short stature was present in 65% of the patients
and was as severe as5.7 SD. In our study, mild truncal
obesity was present in most patients at midchildhood,
but that trait may be lacking in adult patients. Other
studies have described different frequencies of truncal
obesity, from 17%–100% in patients age 8 years
(Kivitie-Kallio and Norio 2001; Chandler et al. 2003).
In contrast to the ﬁndings in Finnish patients with Cohen
syndrome, neutropenia was identiﬁed in only 10/18 pa-
tients (56%); in particular, patients from outside Europe
were found to have a normal neutrophil count. There-
fore, neutropenia is not an obligate sign of Cohen syn-
drome. The degree of mental retardation, especially the
level of speech competence, varied considerably among
our patients. The frequency of nonverbal patients (30%)
seemed to be higher than reported elsewhere (Kivitie-
Kallio and Norio 2001; Chandler et al. 2003). The cran-
iofacial dysmorphism was present but subtle in some of
the younger patients. Whereas myopia was evident in
all patients, retinopathy was not found in some patients
15 years of age, indicating that it is age dependent and
not a consistent feature.
Identiﬁcation of COH1 mutations in two families with
an overlapping phenotype of Cohen and Mirhosseini-
Holmes-Walton syndromes suggests that Mirhosseini-
Holmes-Walton syndrome does not exist as a separate
entity. However, it remains possible that mutations in
another gene account for further cases reported as Mir-
hosseini-Holmes-Walton syndrome.
In summary, a consistent relationship between spe-
ciﬁc mutations and the severity of Cohen syndrome
or the expression of a particular clinical sign has not
been observed, with the exception of the mutation
c.3348_3349delCT, found solely in Finnish patients. Re-
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Figure 4 Phylogenetic tree of sequences with similarities to the deduced product of COH1. The corresponding gene names are given.
The species are listed in square brackets; Ag p Anopheles gambiae; At p Arabidopsis thaliana; Dd p Dictyostelium discoideum; Dm p
Drosophila melanogaster; Ec p Encephalitozoon cuniculi; Hs p Homo sapiens; Mm p Mus musculus; Rn p Rattus norvegicus; Sc p
Saccharomyces cerevisiae; and Sp p Schizosaccharomyces pombe. The names of the gene products, when available, are shown in parentheses,
and Vps p associated with vacuolar protein sorting.
sults from the present study raise the total number of
different mutations known in COH1 to 26. Our inves-
tigation of an ethnically diverse series of patients with
Cohen syndrome revealed that, besides developmental
delay, myopia and, in particular, the typical facial gestalt
were major signs of Cohen syndrome caused by COH1
mutations. COH1 mutations may be present also in pa-
tients lacking retinopathy at school age, microcephaly,
or neutropenia. Finally, these data demonstrate that
COH1 is subject to wide allelic heterogeneity, and there
seems to be no major mutational hotspot in non-Finnish
patients with Cohen syndrome.
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